Chronic lithium treatment protects against liver ischemia/reperfusion injury in rats

Liver Transplantation

Volumn 19, Issue 7, 2013, Pages 762-772

  Liu, Anding ^a,b   Fang, Haoshu ^b,c   Dahmen, Uta ^b   Dirsch, Olaf ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3BETA; HIGH MOBILITY GROUP B PROTEIN; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DRUG DOSE TITRATION; ENZYME ACTIVATION; HISTOPATHOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CYTOKINES; GLYCOGEN SYNTHASE KINASE 3; HMGB PROTEINS; INFLAMMATION; LITHIUM CHLORIDE; LIVER; LIVER DISEASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSAMINASES;

EID: 84879526538     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23666     Document Type: Article

References (49)

1. Fondevila C, Busuttil RW, Kupiec-Weglinski JW,. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 2003; 74: 86-93.
2. Gurusamy KS, Gonzalez HD, Davidson BR,. Current protective strategies in liver surgery. World J Gastroenterol 2010; 16: 6098-6103.
3. Bauer M, Alda M, Priller J, Young LT,; for International Group for the Study of Lithium Treated Patients (IGSLI). Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 2003; 36 (suppl 3): S250-S254.
4. Chuang DM, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002; 4: 129-136.
5. Talab SS, Emami H, Elmi A, Nezami BG, Assa S, Deroee AF, et al. Chronic lithium treatment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways. Eur J Pharmacol 2010; 647: 171-177.
6. Han R, Gao B, Sheng R, Zhang LS, Zhang HL, Gu ZL, Qin ZH,. Synergistic effects of prostaglandin E1 and lithium in a rat model of cerebral ischemia. Acta Pharmacol Sin 2008; 29: 1141-1149.
7. Bian Q, Shi T, Chuang DM, Qian Y,. Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils. Brain Res 2007; 1184: 270-276.
8. Faghihi M, Mirershadi F, Dehpour AR, Bazargan M,. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart. Eur J Pharmacol 2008; 597: 57-63.
9. Ren M, Senatorov VV, Chen RW, Chuang DM,. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci U S A 2003; 100: 6210-6215.
10. Li H, Li Q, Du X, Sun Y, Wang X, Kroemer G, et al. Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 2011; 31: 2106-2115.
11. Barillas R, Friehs I, Cao-Danh H, Martinez JF, del Nido PJ,. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts. Ann Thorac Surg 2007; 84: 126-133.
12. Chalecka-Franaszek E, Chuang DM,. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 1999; 96: 8745-8750.
13. Xia Y, Wang CZ, Liu J, Anastasio NC, Johnson KM,. Lithium protection of phencyclidine-induced neurotoxicity in developing brain: the role of phosphatidylinositol-3 kinase/Akt and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling pathways. J Pharmacol Exp Ther 2008; 326: 838-848.
14. Wada A,. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 2009; 110: 14-28.
15. Xu J, Culman J, Blume A, Brecht S, Gohlke P,. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 2003; 34: 1287-1292.
16. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005; 170: 1101-1111.
17. Glick D, Barth S, Macleod KF,. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221: 3-12.
18. Klionsky DJ, Emr SD,. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.
19. Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R,. Autophagy in liver diseases. J Hepatol 2010; 53: 1123-1134.
20. Kang K, Kim YJ, Kim YH, Roh JN, Nam JM, Kim PY, et al. Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats. Neurol Res 2012; 34: 447-454.
21. Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK, Brenner DA,. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 2005; 42: 850-859.
22. Liu A, Dirsch O, Fang H, Dong W, Jin H, Huang H, et al. HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats. Exp Mol Pathol 2011; 91: 502-508.
23. Moloney WC, Mcpherson K, Fliegelman L,. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960; 8: 200-207.
24. Xing W, Deng M, Zhang J, Huang H, Dirsch O, Dahmen U,. Quantitative evaluation and selection of reference genes in a rat model of extended liver resection. J Biomol Tech 2009; 20: 109-115.
25. Liu A, Dirsch O, Fang H, Sun J, Jin H, Dong W, Dahmen U,. HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat. Histochem Cell Biol 2011; 135: 443-452.
26. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135-1143.
27. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 1997; 25: 1128-1135.
28. Malhi H, Gores GJ, Lemasters JJ,. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43 (suppl 1): S31-S44.
29. Xia Y, Rao J, Yao A, Zhang F, Li G, Wang X, Lu L,. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB- mediated protective signaling in mice. Eur J Pharmacol 2012; 697: 117-125.
30. Dehpour AR, Ghafourifar P, Samenian J, Sadeghipour HR, Sadr SS,. The effect of lithium on endothelial-dependent relaxation in rat isolated aorta. Gen Pharmacol 1995; 26: 1003-1007.
31. Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A,. Liver ischemia/reperfusion injury: processes in inflammatory networks-a review. Liver Transpl 2010; 16: 1016-1032.
32. Du Q, Park KS, Guo Z, He P, Nagashima M, Shao L, et al. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res 2006; 66: 7024-7031.
33. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A,. HMGB1: endogenous danger signaling. Mol Med 2008; 14: 476-484.
34. Lotze MT, Tracey KJ,. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342.
35. Ren F, Duan Z, Cheng Q, Shen X, Gao F, Bai L, et al. Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism. Hepatology 2011; 54: 687-696.
36. Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH,. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. Hepatobiliary Pancreat Dis Int 2012; 11: 278-284.
37. Cohen P, Goedert M,. GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 2004; 3: 479-487.
38. Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A,. Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol 2009; 156: 885-898.
39. Kockeritz L, Doble B, Patel S, Woodgett JR,. Glycogen synthase kinase-3-an overview of an over-achieving protein kinase. Curr Drug Targets 2006; 7: 1377-1388.
40. Forde JE, Dale TC,. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007; 64: 1930-1944.
41. Klein PS, Melton DA,. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996; 93: 8455-8459.
42. Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS,. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 2003; 278: 33067-33077.
43. Fu H, Chen H, Wang C, Xu H, Liu F, Guo M, et al. Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3β signaling and mitochondrial permeability transition. Mol Med 2012; 18: 1128-1135.
44. Czaja MJ, Liu H, Wang Y,. Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling. Hepatology 2003; 37: 1405-1413.
45. Li Q, Li H, Roughton K, Wang X, Kroemer G, Blomgren K, Zhu C,. Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis 2010; 1: e56.
46. Chen RW, Qin ZH, Ren M, Kanai H, Chalecka-Franaszek E, Leeds P, Chuang DM,. Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem 2003; 84: 566-575.
47. Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET,. Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 2003; 23: 6027-6036.
48. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M,. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008; 117: 2761-2768.
49. Kim JS, He L, Lemasters JJ,. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003; 304: 463-470.